TG Therapeutics Statistics
Total Valuation
TGTX has a market cap or net worth of $3.69 billion. The enterprise value is $3.58 billion.
Important Dates
The next estimated earnings date is Friday, November 8, 2024, before market open.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TGTX has 143.45 million shares outstanding. The number of shares has increased by 8.81% in one year.
| Shares Outstanding | 143.45M |
| Shares Change (YoY) | +8.81% |
| Shares Change (QoQ) | +9.04% |
| Owned by Insiders (%) | 6.95% |
| Owned by Institutions (%) | 76.36% |
| Float | 133.48M |
Valuation Ratios
The trailing PE ratio is 40.23 and the forward PE ratio is 51.20.
| PE Ratio | 40.23 |
| Forward PE | 51.20 |
| PS Ratio | 10.69 |
| Forward PS | 22.78 |
| PB Ratio | 20.77 |
| P/FCF Ratio | 54.38 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 35.13, with an EV/FCF ratio of 52.84.
| EV / Earnings | 37.45 |
| EV / Sales | 10.34 |
| EV / EBITDA | 35.13 |
| EV / EBIT | 35.19 |
| EV / FCF | 52.84 |
Financial Position
The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.64.
| Current Ratio | 3.58 |
| Quick Ratio | 2.77 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 1.08 |
| Debt / FCF | 1.66 |
| Interest Coverage | 8.21 |
Financial Efficiency
Return on equity (ROE) is 87.78% and return on invested capital (ROIC) is 28.94%.
| Return on Equity (ROE) | 87.78% |
| Return on Assets (ROA) | 20.47% |
| Return on Capital (ROIC) | 28.94% |
| Revenue Per Employee | $1.31M |
| Profits Per Employee | $362,443 |
| Employee Count | 264 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 0.45 |
Taxes
In the past 12 months, TGTX has paid $91,000 in taxes.
| Income Tax | 91,000 |
| Effective Tax Rate | 0.10% |
Stock Price Statistics
The stock price has increased by +269.40% in the last 52 weeks. The beta is 2.21, so TGTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.21 |
| 52-Week Price Change | +269.40% |
| 50-Day Moving Average | 23.47 |
| 200-Day Moving Average | 18.48 |
| Relative Strength Index (RSI) | 64.48 |
| Average Volume (20 Days) | 2,358,222 |
Short Selling Information
The latest short interest is 32.48 million, so 22.64% of the outstanding shares have been sold short.
| Short Interest | 32.48M |
| Short Previous Month | 34.40M |
| Short % of Shares Out | 22.64% |
| Short % of Float | 24.34% |
| Short Ratio (days to cover) | 7.76 |
Income Statement
In the last 12 months, TGTX had revenue of $346.72 million and earned $95.69 million in profits. Earnings per share was $0.64.
| Revenue | 346.72M |
| Gross Profit | 321.62M |
| Operating Income | 101.84M |
| Pretax Income | 95.78M |
| Net Income | 95.69M |
| EBITDA | 102.00M |
| EBIT | 101.84M |
| Earnings Per Share (EPS) | $0.64 |
Full Income StatementBalance Sheet
The company has $217.25 million in cash and $112.92 million in debt, giving a net cash position of $104.33 million or $0.73 per share.
| Cash & Cash Equivalents | 217.25M |
| Total Debt | 112.92M |
| Net Cash | 104.33M |
| Net Cash Per Share | $0.73 |
| Equity (Book Value) | 177.57M |
| Book Value Per Share | 1.24 |
| Working Capital | 280.49M |
Full Balance SheetCash Flow
| Operating Cash Flow | 67.82M |
| Capital Expenditures | n/a |
| Free Cash Flow | 67.82M |
| FCF Per Share | $0.47 |
Full Cash Flow StatementMargins
Gross margin is 92.76%, with operating and profit margins of 29.37% and 27.60%.
| Gross Margin | 92.76% |
| Operating Margin | 29.37% |
| Pretax Margin | 27.62% |
| Profit Margin | 27.60% |
| EBITDA Margin | 29.42% |
| EBIT Margin | 29.37% |
| FCF Margin | 19.56% |
Dividends & Yields
TGTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.81% |
| Shareholder Yield | -8.81% |
| Earnings Yield | 2.59% |
| FCF Yield | 1.84% |
Dividend DetailsAnalyst Forecast
The average price target for TGTX is $33.60, which is 30.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.60 |
| Price Target Difference | 30.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 41.38% |
| EPS Growth Forecast (5Y) | 112.98% |
Stock ForecastsStock Splits
The last stock split was on April 30, 2012. It was a reverse split with a ratio of 0.0177777:1.
| Last Split Date | Apr 30, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0177777:1 |
Scores
TGTX has an Altman Z-Score of 2.6 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.6 |
| Piotroski F-Score | 6 |